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Herbal medicine use has grown considerably worldwide among pregnant women, and is
particularly widespread in sub-Saharan Africa. However, herbal medicines used across
sub-Saharan Africa are associated with important research gaps and a lack of regulatory
framework. This is particularly problematic, as herbal medicine use during pregnancy
raises several concerns attributed to the herbal ingredient itself, conventional drug-herbal
medicine interactions, and contamination or adulteration of herbal remedies. Moreover,
several local herbal remedies used by sub-Saharan African pregnant women have never
been botanically identified. In this review, an overview of the practice of herbal medicine,
including the regulations, challenges and overall safety, is provided. Then, we discuss the
prevalence of herbal medicine use during pregnancy across different sub-Saharan African
countries, as well as the indications, adverse outcomes, and effectiveness of the most
commonly used herbal medicines during pregnancy in that region.
Keywords: herbal medicine, pregnancy, sub-Saharan Africa, traditional medicine, ethnopharmacologyINTRODUCTION
Pregnancy is characterized by significant physiological changes resulting in various symptoms, such
as nausea, vomiting, heartburn, and constipation. These ailments often cause pregnant women to
resort to self-medication including the use of herbal medicines (John and Shantakumari, 2015).
Consequently, the use of herbal medicines has grown considerably worldwide among pregnant
women (Kennedy et al., 2013; Bayisa et al., 2014; John and Shantakumari, 2015). The prevalence of
herbal medicine use during pregnancy varies significantly, depending on the geographic location,
ethnicity, cultural traditions, and socioeconomic status (Illamola et al., 2020). In a multinational,
cross-sectional, internet-based study conducted among 9,459 pregnant women from 23 countries in
Western Europe (n = 3,201), Northern Europe (n = 2,820), Eastern Europe (n = 2,342), North
America (n = 533), South America (n = 346), and Australia (n = 217), 28.9% of women reported
herbal medicine use during pregnancy. Russia (69.0%), Poland (49.8%), and Australia (43.8%) had
the highest reported rates of herbal medicine users (Kennedy et al., 2013). The prevalence of herbal
medicine use in pregnancy has also been reported in various other countries, including Iran (49.2%),
Egypt (27.3%), Bangladesh (70.0%), Iraq (53.7%), Palestine (40.0%), and Taiwan (33.6%) (Chuangin.org June 2020 | Volume 11 | Article 8661
El Hajj and Holst Herbal Medicine Use During Pregnancyet al., 2009; Khadivzadeh and Ghabel, 2012; Al-Ramahi et al.,
2013; Orief et al., 2014; Hwang et al., 2016; Ahmed et al., 2018a).
Previous research has shown that herbal medicine use during
pregnancy is quite common across sub-Saharan Africa (Ahmed
et al., 2018b). However, in several sub-Saharan African countries,
there is a paucity of data on the use of herbal medicines among
pregnant women. The following paper presents an in-depth
literature review which aims to provide the best available
information on herbal medicine (safety, regulations, and
challenges). This review also identifies the prevalence of herbal
medicine use during pregnancy across different sub-Saharan
African countries, and summarizes information on the
indications, adverse outcomes, and effectiveness of the most
commonly used herbal medicines during pregnancy in that
region. Herein, we reviewed both published and unpublished
studies, drafted in English or French, reporting on herbal
medicine use during pregnancy in any sub-Saharan African
country, including observational studies, qualitative studies,
and meta-analyses. A systematic literature search was
conducted between December 2018 and February 2020, by
searching the electronic databases MEDLINE and Google
Scholar, and through checking reference lists for the
identification of additional, relevant studies.CHALLENGES ASSOCIATED WITH THE
HERBAL MEDICINE PRACTICE
According to the World Health Organization, there are several
challenges associated with the herbal medicine practice
(Figure 1), which are related to regulatory status, assessment
of safety and efficacy, quality control, safety monitoring, and lack
of knowledge about herbal medicine within national drug
regulatory authorities (World Health Organization, 2005).
The diversity of herbal remedies and their uses between
different countries makes scientifically evaluating and
regulating them very challenging (Wachtel-Galor and Benzie,
2011). Hence, in some countries, herbal medicines are subjected
to rigorous manufacturing standards, while in others, they are
regarded as food supplements for which therapeutic claims areFrontiers in Pharmacology | www.frontiersin.org 2prohibited. For example, in Europe, the Directive 2001/83/EC
and the Directive 2004/24/EC divide herbal medicines into two
categories: “well-established herbal medicinal products” and
“traditional herbal medicinal products”. For the first category,
it is needed to demonstrate with sound bibliographic data that
the herbal medicinal product has a well-established medicinal
use with recognized efficacy and an acceptable level of safety. The
herbal medicine product should have a history of safe and
efficacious use for at least 10 years within the European Union
for a well-established use registration. For the second category,
manufacturers of herbal medicines are required to demonstrate
that the safety and effectiveness of the traditional herbal
medicinal product are based on long-standing medicinal use:
30 years worldwide, including at least 15 years in the European
Union (Wachtel-Galor and Benzie, 2011). In the United States,
by contrast, the Dietary Supplement Health and Education Act of
1994 classifies herbal products as dietary supplements, a product
category that does not require pre-approval. Consequently, the
manufacturer is responsible for ensuring that a herbal product is
safe before it is marketed, and the Food and Drug
Administration can only take regulatory action against any
unsafe herbal product after it reaches the market. Therefore, in
contrast to prescription and newer over-the-counter
medications, herbal products in the United States are usually
marketed without the benefit of clinical trials to demonstrate
either efficacy or safety (Broussard et al., 2010). In sub-Saharan
Africa, the development of national policies and regulations for
herbal medicines is substantially more limited, resulting in the
proliferation of both locally produced and imported herbal
remedies of dubious quality, safety, and efficacy (World Health
Organization, 2005). For instance, in Zambia, although the
Medicines and Allied Substances Act of 2013 mandates the
Zambia Medicines Regulations Authority to regulate and
control the sales of herbal medicines, there is neither a system
of registration nor a post-marketing surveillance system for
herbal medicines (World Health Organization, 2005; Lusaka
Times, 2018). Similarly, in Kenya, although the 2005 National
Policy on Traditional Medicine and Medicinal Plants stressed the
need to take inventory of all herbal medicines available in the
country, these recommendations have yet to be implemented
(Okumu et al., 2017).FIGURE 1 | Challenges associated with the herbal medicine practice. MENA, Middle East and North Africa; QC, quality control; USA, United States of America.June 2020 | Volume 11 | Article 866
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toxicity problems of herbal medicines can be attributed to a
lack of proper standardization and quality control in the formal
herbal industry (Mensah et al., 2019; Ozioma and Chinwe, 2019).
Indeed, there is a close correlation between the safety and efficacy
of herbal medicines and the quality of the source materials used
in their production. The quality of source materials is, in its turn,
determined by intrinsic (genetic) and extrinsic (environmental)
factors (e.g., exposure to light; availability of water; temperature
of processing; period, time, and method of harvest; drying,
packing, transportation, and storage of raw herbal material,
etc.). Therefore, it is challenging to perform quality controls on
the raw materials of herbal medicines, especially given that many
countries lack operative machinery needed to implement good
manufacturing practices (World Health Organization, 2005).
Quality control of herbal medicines is also made more difficult
by the seasonal variations in the content of the medicinal plant
parts and thus the potential quantitative changes in the
composition and/or ratios of bioactive ingredients (Anwar
et al., 2016). In addition, there is a paucity of research on
whole herbal mixtures partially because the drug approval
process does not accommodate undifferentiated mixtures of
natural chemicals (Wachtel-Galor and Benzie, 2011). Another
source of toxicity of herbal medicines that is important to
mention is adulteration of herbal products with undeclared
pharmaceutical drugs and potentially toxic compounds such as
harmful molecules present in other adulterating botanicals,
pathogenic microorganisms, toxins, pesticides, agrochemical
residues, and heavy metals (e.g., lead, mercury, and arsenic)
(Saper et al., 2004; Mensah et al., 2019). Incorrect identification
of plants may also lead to the inadvertent use of potentially toxic
species. Furthermore, toxicity may arise as a result of herb-drug
interactions (Ozioma and Chinwe, 2019). For example, it has
been shown that a pharmacokinetic interaction exists between
the antimalarial drug amodiaquine and Moringa oleifera Lam., a
commonly used medicinal plant with multiple health benefits,
when given together or following a long period of ingestion of
Moringa oleifera Lam. In the presence of Moringa oleifera Lam.,
the peak plasma concentration of amodiaquine decreased by up
to 40%, as well as its area under the plasma concentration-time
curve which decreased by approximately 11%, leading to a
significantly delayed absorption of amodiaquine (Olawoye
et al., 2018). Overall, establishing herbal toxicity can be
difficult. Even when herbal-related toxicity is suspected, a
definitive diagnosis is difficult to establish without proper
analysis of the product or plant material (Ozioma and
Chinwe, 2019).
Because of the potential toxicity and safety concerns related to
herbal products, there is a need to establish a pharmacovigilance
system of herbal medicines that is integrated within communities
and health facilities, so that data regarding their composition,
preparation, indications, and adverse events can be gathered
(Ahmed et al., 2018a). The latency period between the use of an
herbal product and the occurrence of an adverse event should also
be determined, if possible, as this can help in causality assessment in
pharmacovigilance management. Such information can facilitateFrontiers in Pharmacology | www.frontiersin.org 3decisions on further protective measures to be taken concerning the
future use of herbal medicines (Ozioma and Chinwe, 2019).
Research is also needed to meet the challenges of identifying the
active compounds in the plants, and there should be research-based
evidence on the safety and efficacy of both whole herbs and
extracted compounds (Wachtel-Galor and Benzie, 2011).
Regrettably, the expanding herbal product market could lead to
overharvesting of plants and threaten the rich biodiversity in sub-
Saharan Africa. In addition, poorly managed collection and
cultivation practices could contribute to the extinction of
endangered plant species and the destruction of natural resources
(Wachtel-Galor and Benzie, 2011). It has been suggested that 15,000
medicinal plant species are threatened with extinction (Brower,
2008). Another negative consequence of this trend is that there will
be essentially less choice for the future development of medicines, if
the situation is not addressed (Brower, 2008). Under these
circumstances, forest laws are of considerable importance, as they
have a role in ensuring the sustainable availability of medicinal
plants. A number of countries in sub-Saharan Africa have enacted
forest laws, including the Lesotho Forestry Act of 1978, the
Tanzania Forest Act of 2002, the Namibia Forest Act No. 12 of
2001, the Mozambique Forest and Wildlife Act of 1999, the South
Africa National Forests Act No. 84 of 1998, the Zambia Forests Act
of 1999, and the Zimbabwe Forest Amendment Act of 1999 (Moshi
and Mhame, 2013). However, like other existing laws, these forest
laws have deficiencies, such as failure to link the forest sector
development with economic and social development objectives,
weak forest administrative structures, low or poor compensation
being given to the local communities that are custodians of the
forest resources, poor definition of legal and institutional
frameworks regarding forest management and use, and land
tenure problems (Moshi and Mhame, 2013). Hence, more
international efforts are needed for the preservation of
plant populations.OVERALL SAFETY OF HERBAL MEDICINE
DURING PREGNANCY
The indications for the use of herbal medicines during pregnancy
may vary across regions and countries, and can be mother- or
child-related (Illamola et al., 2020). Herbal medicines may be
used sometimes as part of maternal care to treat pregnancy-
related problems, and often to improve the well-being of the
mother and/or the unborn child. The most commonly reported
indications are nausea and vomiting, urinary tract infections,
preparation for and/or facilitation of labor, common cold or flu,
gastrointestinal problems (e.g., constipation, flatulence), pain
conditions, improvement of fetal outcomes, prevention of
miscarriage, relief of anxiety, treatment and/or prevention of
anemia, and treatment of edema (Kennedy et al., 2013; John and
Shantakumari, 2015; Ahmed et al., 2018b; Illamola et al., 2020).
As previously mentioned, safety concerns related to herbal
products can be mainly attributed to the herbal ingredient itself,
conventional drug-herbal medicine interactions, andJune 2020 | Volume 11 | Article 866
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potentially toxic compounds such as heavy metals (Broussard
et al., 2010). However, herbal medicine use during pregnancy
raises particular concerns, because many herbal products are
specifically marketed for symptoms that occur commonly during
pregnancy, such as nausea and vomiting (Allaire et al., 2000;
Broussard et al., 2010). More importantly, there is a lack of
randomized controlled trial data on the efficacy and safety of
herbal medicine use during pregnancy. In many areas of sub-
Saharan African, secrecy surrounds the practice of herbal
medicine, with the components and preparation methods of
herbal medicines, especially those intended for the treatment of
serious ailments such as malaria and HIV/AIDS, exclusively
residing with traditional healers (International Bioethics
Committee, 2013; Ozioma and Chinwe, 2019). The fact that
there are several plants used in African traditional medicine, for
which little information is available on their constituents, can
increase the risk of adverse reactions, particularly in vulnerable
groups such as older adults, children, and pregnant women
(Mensah et al., 2019; Ozioma and Chinwe, 2019). The use of
unstudied herbal agents with unknown pharmacologic activity
can pose a potential risk to both the pregnant women and their
fetuses (Allaire et al., 2000; Ahmed et al., 2018a). In a 2004 study
investigating herbal medicine use during pregnancy among 400
Norwegian women, approximately 40% of the 144 herbal
medicine users consumed herbal products that were either
potentially harmful or with missing information about their
safety in pregnancy (Nordeng and Havnen, 2004). Similarly, in
a large, multinational study which classified 126 different herbal
medicines used in pregnancy according to their safety, only 28
herbs (22.2%) were deemed as safe to use in pregnancy based on
current literature (Kennedy et al., 2016). More recently, a
systematic review, which aimed to determine whether herbal
medicinal use during pregnancy was associated with adverse
maternal or child outcomes, found that topical use of almond oil
was significantly associated with preterm birth, oral raspberry
leaf with caesarean delivery, and heavy liquorice consumption
(greater than 500 mg/week) with early preterm birth (MunozFrontiers in Pharmacology | www.frontiersin.org 4Balbontin et al., 2019). In addition, the use of herbal medicines in
pregnancy constitutes a major challenge for health care
providers, since pregnant women often consume herbal
medicines without consulting them (Illamola et al., 2020).
Hence, in order to further advance research on the benefits
and adverse effects of herbal medicine use during pregnancy, it is
important to determine the extent of herbal medicine use during
pregnancy in different settings and to find out which herbs
pregnant women use.PREVALENCE OF HERBAL MEDICINE
USE DURING PREGNANCY IN SUB-
SAHARAN AFRICA
Sub-Saharan Africa is one region of the world in which herbal
medicine is traditionally and culturally acknowledged (James
et al., 2018b). However, evidence from sub-Saharan Africa
suggests wide variability in the use of herbal medicines during
pregnancy (Figure 2), from 2.0% as reported in a study
conducted in the Tigray Region, Northern Ethiopia
(Gebremedhin and Gomathi, 2014) to 100% according to
another study in Machakos District, Eastern Kenya (Kaingu
et al., 2011). It is difficult to ascertain whether these differences
in prevalence across studies are caused by variability in study
design, setting, data collection, and sampling techniques or
whether they represent true differences in herbal medicine use
(Kennedy et al., 2013; James et al., 2018a). In a recently published
systematic review by Ahmed et al. (2018b) of 50 studies,
including a total of 22,404 African pregnant or lactating
women, the average prevalence of herbal medicine use during
pregnancy among the different African regions was between 32%
(in Central Africa) to 45% (in East Africa). This systematic
review also found that herbal medicine use during pregnancy was
statistically significantly associated (p < 0.05) with a lower
educational level, increasing age, being married, low
socioeconomic status, lower educational level of the spouse,FIGURE 2 | Estimated prevalence of herbal medicine use during in pregnancy in selected sub-Saharan African countries. *The prevalence rate for Ethiopia was
based on a recent meta-analysis of eight studies (Adane et al., 2020).June 2020 | Volume 11 | Article 866
El Hajj and Holst Herbal Medicine Use During Pregnancypoor pregnancy outcomes, herbal medicine use in prior
pregnancies, perception that medicinal plants are effective,
large family size, self-employment, unemployment, and rural
residence (Ahmed et al., 2018b). Table 1 illustrates the
characteristics and findings of selected cross-sectional studies
evaluating the use of herbal medicines among pregnant women
in different sub-Saharan countries.
The popularity of herbal medicines among pregnant women
can be mainly attributed to the belief that herbal products, being
natural, are safe with fewer adverse events compared to
conventional drugs (Ernst, 2002; Barnes et al., 2018; Peprah
et al., 2019). Additionally, several studies have shown that
pregnant women in sub-Saharan Africa, particularly in rural
areas, use herbal medicines because they consider them less
costly and more accessible than conventional drugs (Bayisa et al.,
2014; Batisai, 2016; Ahmed et al., 2018a; Peprah et al., 2019). Of
note, the ratio of traditional healers to the population in sub-
Saharan Africa is 1:500, whereas the ratio of medical doctors to
the population is 1:40,000, and most medical doctors are
concentrated in urban areas and cities at the expense of rural
areas (Abdullahi, 2011). Herbal medicine use was also shown to
be in line with the sociocultural, religious and spiritual values of
the people who use it in sub-Saharan Africa (Batisai, 2016; James
et al., 2018b; Gakuya et al., 2020). Indeed, in many parts of sub-
Saharan Africa, traditional medicine defines illness as a
consequence of a breakdown of social balance (e.g., breaking
codes of conduct in the present or in the past, ancestor or evil
spirits, as well as witchcraft or fate) (Ahlberg, 2017; Stephani
et al., 2018). Moreover, according to Pretorius (1991), the use of
herbal medicine post-independence became one of the ways sub-
Saharan Africans deployed to “rediscover their sociocultural
identity”, and to deal with inaccessible and expensive
medicines foreign to them (Pretorius, 1991).MOST COMMONLY USED HERBAL
MEDICINES DURING PREGNANCY IN
SUB-SAHARAN AFRICA
Due to differences in culture, traditions, and climate, it is
expected that herbal medicines used during pregnancy vary
across countries and regions. In the multinational study by
Kennedy et al. (2013) in 9,459 pregnant women from 23
countries in Europe, North and South America, and Australia,
the most frequently used herbal medicines were Zingiber
officinale Roscoe (ginger), Vaccinium oxycoccus L./Vaccinium
macrocarpon Aiton L. (cranberry), Valeriana officinalis L.
(valerian), Rubus idaeus L. (raspberry leaf), Matricaria
chamomilla L. (chamomile), and Mentha piperita L.
(peppermint) (Kennedy et al., 2013). The African continent,
generally known for its rich biodiversity, has an estimated total
flora of over 70,000 species (Govaerts, 2001). This species
richness was reflected in the systematic review by Ahmed et al.
in which a total of 274 different medicinal plant species from 87
plant families were reported to be used during pregnancyFrontiers in Pharmacology | www.frontiersin.org 5(Ahmed et al., 2018b). The most commonly cited medicinal
plant species were Zingiber officinale Roscoe (ginger), Allium
sativum L. (garl ic) , Cucurbita pepo L. (pumpkin) ,
Gymnanthemum amygdalinum (Delile) Sch.Bip. (syn. Vernonia
amygdalina Delile) (bitter leaf), Ricinus communis L. (castor oil),
Garcinia kola Heckel (bitter kola), Ocimum lamiifolium Hochst.
ex Benth. (basil or Dama Kesse in Amharic), Azadirachta indica
A. Juss (neem), Ruta chalepensis L. (Tena Adam, in Amharic;
fringed rue in English), and Aloe vera (L.) Burm.f. (Aloe vera)
(Ahmed et al., 2018b). Table 2 presents the most commonly used
herbal medicines during pregnancy, based on the Kennedy et al.
(2013) multinational study and the Ahmed et al. (2018b)
systematic review.
Several cross-sectional studies have shown that ginger is
commonly used by pregnant women across sub-Saharan Africa
for nausea and vomiting during pregnancy (Laelago et al., 2016;
Shewamene et al., 2017; Ahmed et al., 2018b). A systematic
review of 12 randomized controlled trials involving 1,278
pregnant women found that ginger significantly improved the
symptoms of nausea when compared to placebo (p < 0.001), with
subgroup analyses favoring the lower daily dosage of <1.5 g of
ginger for nausea relief (Viljoen et al., 2014). This finding is not
surprising, given that animal studies have shown that ginger can
increase gastric contractility, speed up gastric emptying, and
consequently increase the gastrointestinal transit time of meals,
which can decrease the feeling of nausea (Chrubasik et al., 2005).
However, in the systemic review by Viljoen and colleagues,
ginger did not have a significant impact on vomiting episodes
(p = 0.06 versus placebo). It was also associated with a favorable
safety profile, as it did not pose a risk for spontaneous abortions
or for other adverse events such as heartburn or drowsiness
(Viljoen et al., 2014).
Garlic is characterized by diverse therapeutic properties,
including anti-hypertensive, anti- inflammatory, anti-oxidant,
anti-bacterial, hypocholesteremic, and anti-cancer properties
(Al Disi et al., 2016). In a randomized, single-blind, placebo-
controlled study among 100 nulliparous pregnant women, the
administration of 800 mg/day of garlic tablets during the third
trimester of pregnancy was found to be effective in reducing the
occurrence of hypertension (p = 0.043 versus placebo) and in
lowering serum cholesterol levels (p = 0.038). However,
compared to placebo, garlic consumption was associated with a
slightly higher incidence of nausea (Ziaei et al., 2001). A meta-
analysis of 18 randomized, placebo-controlled trials also found
that garlic supplements induce a significant reduction in both
systolic and diastolic blood pressure by 3.75 and 3.39 mmHg,
respectively (p < 0.001 compared to placebo) (Wang et al., 2015).
Although the mechanism of garlic’s anti-hypertensive effect
remains unclear, it has been reported that garlic may elicit its
anti-hypertensive effects by inhibition of angiotensin-converting
enzymes through its bioactive compound allicin (Wang et al.,
2015; Al Disi et al., 2016). It is recommended for pregnant
women to avoid using garlic prior to surgery including caesarean
section, as garlic was reported to have an anti-hemostatic effect
and may consequently interfere with blood clotting (Al Disi et al.,
2016; Laelago, 2018).June 2020 | Volume 11 | Article 866


















1,128 21% Not reported Not reported - Users were not different from non-users in
terms of age, education, ethnicity, or
income
- Users were more likely to drink alcohol
during pregnancy, have at least two sex
partners, engage in “dry sex”, initiate sex
with their partner, report a previously
treated sexually transmitted disease, and
use contraception (all p < 0.01)
64% of users did
not want to share














- Herbal medicine use was not associated
with residence area, age, or education level
- Sociocultural beliefs were the major
factors that contributed to use of herbal
medicine during pregnancy
- Most users were unaware of health risks
associated with administering crude herbal









134 62.7% Luffa acutangula (L.)







- Pregnant women who identified as
Muslims were 3.4 times more likely (p =
0.006) than Christian women to use herbal
medicine
- Perceived effectiveness and safety of
herbal medicines over conventional
medicines (70.2%) was the main reason for
use




















- Herbal medicine use in pregnancy was
significantly associated with being in the
20–25 age group (p = 0.021), nulliparity (p
= 0.004), nulligravidity (p = 0.002), and
residing in a high-density neighborhood (p =
0.04)
- Almost all herbal medicine interventions








398 69.9% Fadogia ancylantha
Schweinf., okra
(Abelmoschus esculentus






No association was noted between herbal








400 55% Not reported Labor induction,
to improve fetal
outcomes
- The use of herbal medicines during
pregnancy was associated with long
distance to the nearest public health facility,
and low education level (all p ≤ 0.01)
- The insufficient effectiveness of
conventional medicines (64.1%) and the
accessibility of herbal medicines (30.5%)
















- Age, educational status, marriage,
ethnicity, and source of information were
not associated with herbal medicine use
- About 70% of users were pregnant



















Being in the first trimester of pregnancy,
having less education, and having less
knowledge about herbal medicine favored
the use of medicinal plants
Not reported
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El Hajj and Holst Herbal Medicine Use During PregnancySimilarly to garlic, pumpkin is also known for its multiple
beneficial effects, such as anti-diabetic, anti-hypertensive, anti-
tumor, anti-bacterial, anti-viral, anti-fungal, hypocholesteremic,
anti-ulcer, anti-inflammatory, and analgesic effects (JafarianFrontiers in Pharmacology | www.frontiersin.org 7et al., 2012; Adnan et al., 2017). Protein-bound polysaccharides
and pectines, found in different species of Cucurbita, could exert
anti-oxidant effects by elevating glutathione peroxidase and
























- Rural residency, having no formal
education, and having an average monthly
income <100 United States Dollars were
found to be strong predictors of herbal
medicine use
- 68.4% of users consumed herbal
medicines during their third trimester














595 67.5% Not reported Not reported - Age (p = 0.003), geographical zones (p =
0.02), and educational status (p = 0.04)
were significantly associated with herbal
medicine use
- Users used medicinal plants because they
perceived them as being more effective
than conventional medicines (22.4%), and
safe (21.1%)
- 56.6% of participants did not support
combining herbal medicines with










500 31.4% Ginger, garlic Not reported - Use of herbal medicine was significantly
associated with no formal education and
low socioeconomic status (p < 0.05 for
both)
- Over 40% of women reported combined








500 36.8% Bitter leaf
(Gymnanthemum
amygdalinum (Delile)
Sch.Bip.), palm kernel oil,
bitter kola (Garcinia kola
Heckel)
Not reported Being married (p < 0.001), having no formal
education (p < 0.001), and having a
monthly income >250 USD (p = 0.003)
were significantly associated with herbal










209 79.9% Lippia chevalieri Moldenke,
Combretum micranthum
G. Don, Parkia biglobosa










- Sociodemographic characteristics were
not associated with the use of herbal
medicines
- Frequent use of herbal medicines was

















- The use of herbal medicine was
associated with a lower level of education
(p = 0.007), and use before the index
pregnancy (p < 0.001)
- 51% of users reported use of combined




















- Women who used herbal medicines in
their previous pregnancies were 8 times
more likely to use them during the current
pregnancy
- Residing more than 5 km from the nearest
health facility was associated with increased
herbal medicine
89.7% of the users
of herbal medicines
did not disclose the
use of local herbs









384 6.5% Senna occidentalis (L.)
Link, Sida acuta Burm.f.,
Cola gigantea A.Chev.
To ease labor and
to improve fetal
outcomes
High usage was found among married
women, and among those with no formal
education, and women with median age of
25 years
Not reportedJune 2020 | Volume 11 | Article 866
El Hajj and Holst Herbal Medicine Use During Pregnancyof malondialdehyde (Mahmoodpoor et al., 2018). In addition,
enhancement of splenic lymphocyte proliferation, natural killer
cell activity, and an increase in the number of CD4+, CD8+ T
cells, and the CD4+/CD8+ ratio by pumpkin extracts have been
reported, confirming the immuno-modulatory activity of
pumpkin (Xia et al., 2003). Despite the long-standingFrontiers in Pharmacology | www.frontiersin.org 8medicinal use of pumpkin, there are no clinical trial data
available to support its use during pregnancy and lactation.
Bitter leaf is a perennial plant growing predominantly in
tropical Africa. It has gained wide application in Nigeria,
Uganda, Ethiopia, Tanzania, and other sub-Saharan African





Indication(s) Reported adverse events Common preparation(s) References
Ginger Zingiber officinale
Roscoe
Nausea, vomiting Drowsiness, reflux, vomiting, heartburn,
headache, abdominal discomfort,
preterm delivery, smaller head
circumference of newborns
Ginger tea; chewing raw
ginger
(Holst et al., 2011; Dante







Urinary tract infections Gastrointestinal upset, spotting in the
second and third trimesters
Cranberry juice (Holst et al., 2011;
Heitmann et al., 2013;
Dante et al., 2014)
Valerian Valeriana
officinalis L.
Sleep disorders Diarrhea Root decoction; capsules (Bent et al., 2006)
Raspberry
leaf
Rubus idaeus L. Nausea, increase in milk
production, labor induction
Hypoglycemia, higher percentage of
cesarean deliveries versus non-users
Raspberry leaf tea; capsules (Nordeng et al., 2011;
Al-Ramahi et al., 2013;






insomnia, joint pain, relaxation
Breast engorgement and tenderness,
low birth weight, preterm delivery
Chamomile tea prepared from
dried flowers
(Al-Ramahi et al., 2013;
Trabace et al., 2015;






Heartburn, dry mouth, belching, rash,
dizziness, headache
Leaf tea; oil extract (Al-Ramahi et al., 2013;
Alammar et al., 2019)
Garlic Allium sativum L. Prophylaxis of preeclampsia,
preterm birth prophylaxis,
enhancing the immune system
Foul odor, nausea Eating raw garlic; garlic tea;
garlic juice
(Ziaei et al., 2001; Myhre





fever, common cold, headache,
heartburn, gastrointestinal
irritation, edema
No adverse events were identified in
the literature
Decoction of seeds; leaf juice
(mixed with milk)
(Adnan et al., 2017;






strengthening the pelvic floor
muscles, malaria, anemia
Stimulation of uterine motility Leaf soup; fresh leaves are
washed and squeezed in clean
water and the water is
extracted for drinking
(Attah et al., 2012;
Olowokere and Olajide,







Inducing labor Nausea, abdominal pain, uterine
rupture
Leaves or roots soaked in hot
or cold water, usually drank at
labor onset
(Sicuranza and Figueroa,
2003; Dante et al., 2014;
Gilad et al., 2018)
Bitter kola Garcinia kola
Heckel
Nausea, vomiting Weight loss, prolonged sleep duration,
increased libido
Chewing the seeds (Adegbehingbe et al.,











joint pain, back pain, common
cold, cough, eye infections
No adverse events were identified in
the literature
Oral decoction of crushed
leaves; leaf juice drank or
sniffed or used as an eye drop
(Hailemeskel et al.,












Body smeared with mashed
leaves; neem leaf tea; oral
neem bark extracts
(Mishra and Dave, 2013;
Malan et al., 2015; Dika









Nausea, vomiting, common cold,
abdominal discomfort
Sedation, drowsiness Leaf tea; leaf juice (Al-Said et al., 1990;
Ahmed et al., 2018b)




Itching, rash Topical gel; lotion; leaf tea; leaf
juice
(Cuzzolin et al., 2010;
Facchinetti et al., 2012;
Ahmed et al., 2018b)June 2020 | Volume 11 | Article 866
El Hajj and Holst Herbal Medicine Use During Pregnancyand helminthic infections, and its use is quite popular among
pregnant women (Olowokere and Olajide, 2013; Nalumansi
et al., 2017; Oyeyemi et al., 2018). In a single-arm trial from
Western Uganda examining the efficacy and safety of an oral
bitter leaf infusion in patients aged 12 years and over with
uncomplicated malaria, bitter leaf was associated with an
adequate clinical response after 2 weeks of treatment in 67% of
cases, as well as reduced parasitemia by 32%. No significant
adverse events were reported throughout the trial (Challand and
Willcox, 2009). Although more than 30 bioactive compounds
have been isolated, the sesquiterpene lactones found in the leaves
of Gymnanthemum amygdalinum have been shown to be the
main active compounds responsible for most of the plant’s
therapeutic activities (Luo et al., 2011; Abay et al., 2015;
Oyeyemi et al., 2018). Despite the absence of experimental
studies in pregnant women, a 3-week experiment among 20
pregnant rats found that the aqueous extract of bitter leaf has an
abortifacient effect, and is associated with reduced serum
progesterone levels. The same study also found a median lethal
dose above 5,000 mg/kg, prompting the authors to conclude that
bitter leaf is safe for human consumption (Isa et al., 2014).
Nevertheless, caution is advised with the clinical use of bitter leaf
during pregnancy, and particularly during the first trimester, as it
may stimulate uterine contractions (Olowokere and
Olajide, 2013).
There is a wide use of castor oil to induce labor. In a recent
systematic review and meta-analysis of five randomized
controlled trials and five observational studies aimed at
comparing pregnancy outcomes between users and non-users
of castor oil for labor induction, castor oil users were significantly
more likely to give birth within 24 h than non-users (relative risk,
3.46; 95% confidence interval, 1.58–7.55), highlighting the
oxytocic properties of this medicinal plant (Zamawe et al.,
2018). Castor oil is thought to induce labor via its main
ingredient ricinoleic acid, a hydroxylated fatty acid released
from castor oil by intestinal lipases. Ricinoleic acid specifically
activates the prostaglandin EP3 receptor resulting in laxation and
uterus contraction (Tunaru et al., 2012). With respect to safety,
the systematic review by Zamawe and colleagues found no
statistically significant differences in the rate of hemorrhage,
caesarean section, assisted vaginal delivery, referral to neonatal
intensive care unit, meconium-stained liquor, maternal death,
stillborn, and uterine rupture between users and non-users of
castor oil (Zamawe et al., 2018). Nevertheless, caution should be
exercised, as cases of uterine rupture associated with castor oil
ingestion have been reported in the literature (Sicuranza and
Figueroa, 2003; Fruscalzo et al., 2012).
Bitter kola is a flowering plant found mostly in the tropical
rain forest region of Central and West Africa. Although bitter
kola is mostly used among pregnant women to treat nausea and
vomiting (Ahmed et al., 2018b; Laelago, 2018), reported
pharmacological effects of this plant include anti-diabetic, anti-
inflammatory, antipyretic, immunomodulatory, anti-
atherogenic, anti-microbial, and hepaprotective effects (Okoye
et al., 2014). To our knowledge, there are no available clinical
trial data on bitter kola in pregnant women. However, aFrontiers in Pharmacology | www.frontiersin.org 9randomized, placebo-controlled, double-blind study of bitter
kola in patients with knee osteoarthritis reported a favorable
safety profile of bitter kola, with only minor adverse events (i.e.,
weight loss, prolonged sleep duration, and increased libido)
(Adegbehingbe et al., 2008). These adverse events are not
surprising, given that bitter kola seeds contain approximately
3% of caffeine and 2% of theobromine. Given their relatively high
caffeine content, pregnant women should limit their use.
Dama Kesse is a versatile aromatic genus that is particularly
popular in Ethiopia, with anti-malarial, antipyretic, anti-oxidant,
anti-spasmodic, and anti-bacterial properties (Kefe et al., 2016;
Ahmed et al., 2018b; Sahalie et al., 2018). Despite its widespread
use among pregnant women across Ethiopia (Adane et al., 2020),
Dama Kesse is very poorly studied, with no clinical
studies identified.
Neem is a fast-growing tree that is a member of the Meliaceae
family. It is characterized by a broad spectrum of activity
including anti- inflammatory, antipyretic , analgesic ,
cardiovascular, hypoglycemic, diuretic, immunomodulatory,
dermatological, anti-bacterial, anti-fungal, anti-ulcer, anti-
tumor, and anti-malarial effects. Although its exact mechanism
in the prevention of pathogenesis is not entirely understood, the
therapeutic activity of neem is thought to result from the
synergistic/additive effects of its various bioactive compounds
such as azadirachtin, nimbolinin, nimbin, nimbidin, nimbidol,
sodium nimbinate, gedunin, salannin, and quercetin
(Govindachari et al., 1998; Alzohairy, 2016). Despite being a
native to the Indian subcontinent, neem is commonly used
across sub-Saharan Africa, particularly for malaria prevention
and treatment (Luong et al., 2012; Kumar and Navaratnam,
2013; Malan et al., 2015). Although neem has been extensively
investigated in the non-clinical setting, only a handful of clinical
studies have been published, of which none were conducted in
pregnant women (Alzohairy, 2016). In a small, single-arm
clinical trial among 26 adult patients suffering from gastric
acidi ty and gastroduodenal ulcers , the twice dai ly
administration of 30-mg capsules of neem bark extract for 10
days was associated with a significant decrease of gastric acid
secretion (by 77% compared to baseline; p < 0.002). The volume
of gastric secretion and pepsin activity were also inhibited by
63% and 50%, respectively. Neem showed a favorable safety
profile, with no major adverse events reported (Bandyopadhyay
et al., 2004). In another small, 6-week trial among 36 patients
with oral infections, neem extract dental gel significantly reduced
the plaque index and bacterial count compared to those receiving
chlorhexidine gluconate (0.2% w/v) mouthwash (Pai et al., 2004).
Despite these positive results, case reports in both adults and
children have reported neem oil poisoning incidents causing
vomiting, seizures, hepatic toxicity, metabolic acidosis, and toxic
encephalopathy (Sinniah and Baskaran, 1981; Sundaravalli et al.,
1982; Mishra and Dave, 2013). In addition, oral use of purified
neem seed extract has been found to be efficacious in pregnancy
termination in both rodents and primates, as indicated by a total
decline of chorionic gonadotropin and progesterone and by
resumption of cyclic changes in hormone profiles and perineal
sex swelling in baboons (Talwar et al., 1997). This abortive effectJune 2020 | Volume 11 | Article 866
El Hajj and Holst Herbal Medicine Use During Pregnancyof oral neem seed extracts seems to be propelled by activation of
cell-mediated immune reactions (Atawodi and Atawodi, 2009).
Hence, despite the absence of reliable clinical trial data, the use of
neem preparations during pregnancy should be discouraged.
Tena Adam is a shrubby plant that is cultivated in the
highlands of Ethiopia. Similarly to Dama Kesse, it is poorly
studied with no clinical trial data available. However, the
administration of an aqueous infusion of Tena Adam during
organogenic period in pregnant mice led to increased flow and
decreased vascular resistance in the placenta bed, as well as fetal
thymic involution (Zeichen de Sa et al., 2000). Thus, Tena Adam
should also be discouraged in pregnant women until well-
designed clinical trials are available.
Aloe vera is perhaps one of the most widely used herbal
remedies for topical skin conditions. Aloe vera extracts improve
skin moisture by a humectant mechanism, and prevent skin
ulcers as they contain mucopolysaccharides, amino acids, zinc,
and water (Dal’Belo et al., 2006; Hekmatpou et al., 2019).
Although the topical application of Aloe vera is associated with
infrequent adverse events (Hekmatpou et al., 2019), orally
ingested Aloe vera whole leaf extract has shown clear evidence
of carcinogenic activity in rats, and was classified by the
International Agency for Research on Cancer as a possible
human carcinogen (Guo and Mei, 2016). In addition, pregnant
women are generally not advised to take oral preparations of
Aloe vera because its cathartic property might result in
stimulating uterine contractions, thereby increasing the risk for
premature labor or miscarriage (Guo and Mei, 2016).CONCLUSION
Sub-Saharan Africa is home to an extensive and diverse
medicinal plant life. Consequently, the use of herbal medicines
is widespread in that region. Despite this, the study of herbal
medicine use during pregnancy which is related to maternalFrontiers in Pharmacology | www.frontiersin.org 10health, a public health priority in many sub-Saharan African
countries, remains limited (Wekesah et al., 2016). Currently,
there is not enough information to recommend the safe use of
herbal medicinal products during pregnancy, as most herbal
remedies used across sub-Saharan Africa are not backed by
robust scientific studies. Moreover, several local herbal
remedies used by sub-Saharan African pregnant women have
never been botanically identified. This might be due to the lack of
detailed documentation of traditional knowledge, which is
generally transferred orally. Thus, further research on herbal
medicine use during pregnancy is highly warranted in sub-
Saharan Africa, as it might prevent maternal mortality and
morbidity and decrease the possibility of endangering the
health of fetuses.
A low disclosure rate of herbal medicine use to health care
providers has also been identified in the present review. This
suggests that collaborative communication by health care
providers is important, as it may mitigate against the potential
dangers of herbal medicine use during pregnancy and of
uncoordinated concurrent herbal and conventional medicine
use. Finally, given that traditional and sociocultural influence
may play a role in herbal medicine use during pregnancy, there is
a need to better understand the reasons and facilitators of herbal
medicine use in pregnant women from sub-Saharan Africa.AUTHOR CONTRIBUTIONS
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